As Mexico approaches full legalization of medical cannabis and research, one company has been a driving force. HempMeds Mexico helped tell the story of Raul Elizalde and his 11-year-old daughter Grace: A family in Mexico wins the right to import cannabidiol (CBD) hemp oil to treat Grace’s severe epilepsy.
The Elizalde family’s story spurred an April 28 vote by the Mexican Congress to legalize the use of cannabis for medical and scientific needs.
The bill, which overwhelmingly passed in a general floor vote with 371 in favor, seven against and 11 abstentions, will now be sent to Mexican President Enrique Pena Nieto to be signed into law.
The senate’s vote on this law would have stalled if not for vocal advocacy by Elizalde and HempMeds Mexico, which is a subsidiary of San Diego-based Medical Marijuana, Inc. Elizalde’s daughter Grace lives with Lennon-Gastaut Syndrome. The Elizaldes are well-known proponents of medical cannabis; they sued the federal government and won the right to import cannabidiol (CBD) hemp oil.